Get started
Author

Yuki Sunagawa

Observed names: Sunagawa, Yuki, Y. Sunagawa, YUKI SUNAGAWA, Yuki SUNAGAWA, 砂川, 祐輝, 砂川祐輝
ORCID: 0000-0002-3666-1607
Observed ORCID: 0000-0002-3666-1607
OpenAlex ID: A5040678944
Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer
2019 · Yuki Sunagawa, Suguru Yamada, et al. · Annals of Surgical Oncology · 22
PDF
Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy
2020 · Yuki Sunagawa, Suguru Yamada, et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 19
Comparison of non‐invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma
2019 · Fuminori Sonohara, Suguru Yamada, et al. · Hepatology Research · 19
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)
2018 · Goro Nakayama, Ayako Mitsuma, et al. · The Oncologist · 18
PDF
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
2020 · FUMINORI SONOHARA, SUGURU YAMADA, et al. · Anticancer Research · 17
PDF
Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue
2021 · Yuki Sunagawa, Suguru Yamada, et al. · Scientific Reports · 16
PDF
Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma
2021 · Nobuhiko Nakagawa, Fuminori Sonohara, et al. · Oncology Letters · 11
PDF
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
2020 · NOBUHIKO NAKAGAWA, KATSUHITO TANAKA, et al. · Anticancer Research · 9
PDF
The survival in octogenarians undergoing surgery for pancreatic cancer and its association with the nutritional status
2023 · Suguru Yamada, Kenji Oshima, et al. · Surgery Today · 7
Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy
2021 · Yuki Sunagawa, Masamichi Hayashi, et al. · Clinical Epigenetics · 7
PDF
[Eribulin Administration Methods to Extend the Survival Time of Patients with Advanced or Recurrent Breast Cancer, Consideringthe Relative Dose Intensity, Time to Treatment Failure, Pretreatment Regimen Number, and Tumor Subtype].
2018 · Yuki Sunagawa, Yutaka Mizuno · PubMed · 2
Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).
2018 · Kazuhiro Ezaka, Goro Nakayama, et al. · Journal of Clinical Oncology · 2
Two Cases of Colorectal Cancer with Intussusception Prolapse Through the Anus
2019 · Ikue NONOGAKI, Yuki SUNAGAWA, et al. · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · 1
PDF
A Case of a Pancreatic Lymphoepithelial Cyst with Sebaceous Glands Treated by Laparoscopic Distal Pancreatectomy
2024 · Hiroto Arai, Suguru Yamada, et al. · 日本消化器外科学会雑誌
PDF
Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society
2024 · Shuji Suzuki, Yuko Omori, et al. · Annals of Surgery
Reappraisal of the current resectability criteria and optimal treatment strategies for pancreatic cancer
2024 · Suguru Yamada, Kenji Oshima, et al. · Journal of Gastrointestinal Oncology
Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer
2021 · 砂川, 祐輝 · Nagoya University Repository (NAGOYA Repository)
Abstract 6016: The impact of cancer stem cell markers in the tissues of pancreatic ductal adenocarcinoma for prognosis after surgical resections
2020 · Yoshikuni Inokawa, Suguru Yamada, et al. · Cancer Research
A Case of Laparoscopic Colostomy in a Patient With Defecation Disorder Due to Spinal Cord Injury
2020 · Yuki SUNAGAWA, Ikue NONOGAKI, et al. · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE
PDF
Prognostic impact of preoperative therapy with newer chemotherapeutic regimens followed by conversion surgery for UR-LA pancreatic cancer
2019 · Fuminori Sonohara, Yamada Suguru, et al. · Japanese Society of Hepato-Biliary-Pancreatic Surgery
Clinical impact of CA19-9 and DUPAN-2 level during neoadjuvant therapy in pancreatic cancer
2019 · Yuki Sunagawa, Yamada Suguru, et al. · Japanese Society of Hepato-Biliary-Pancreatic Surgery
局所進行切除不能膵癌に対するGemcitabine+nab-Paclitaxel併用放射線療法
2019 · 高見秀樹, 山田豪, et al.
Randomized phase II trial of CapOX plus bevacizumab versus CapIRI plus bevacizumab as first-line treatment in Japanese patients with metastatic colorectal cancer (CCOG-1201).
2018 · Masahiro Sasahara, Goro Nakayama, et al. · Journal of Clinical Oncology
Administration of Blood Coagulation Factor XIII in Intractable Chylous Ascites following Distal Gastrectomy—A Case Report—
2018 · Yuki SUNAGAWA, Toshio SHIKANO, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
PDF
Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer
2017 · Y. Sunagawa, G. Nakayama, et al. · Annals of Oncology
Works count: 28
Citation count: 150
H-index: 8
I10-index: 7
Year
Topic
Type